NEWSFLASH - Bharat Book Bureau promotes "Conference on Private Equity & Lifesciences 2006"

PRLog (Press Release) – IVCJ is proud to bring to you the first VC&PE centric forum in India , purely focused on the exciting Lifesciences industry. Private Equity has been a noteworthy catalyst of entrepreneurial activity in the pharmaceutical industry. Existing and would-be entrepreneurs and technocrats seriously considering the risk capital route need to understand the expectations of the VC&PE community and bring forward well thought-out business strategies to their table for consideration. On the other side of the coin, the VC&PE community and investors need to understand the returns and challenges of the Lifesciences industry to be able to hone in to the right deals. This exclusive two-day conference, the first of its kind in India, provides a platform for investors and industry players alike to discuss and plan their strategies around a totally new risk and returns milieu. IVCJ aims to bring out an absolute picture of the VC&PE activity taking place in all the 3 sections of lifesciences, namely pharmaceuticals, biotechnology and healthcare. It also aims to bring key decision makers from the of VC&PE and Lifesciences industries to facilitate discussion on key issues and create a conducive networking environment.

Private Equity investments have also seen record growth of about 85% from $1.1 billion in 2004 to $ 2.03 billion in 2005. The VC&PE community's buoyant confidence in this sector was evident by the fact that the LifeSciences sector emerged as one of the leading recipients of funds accounting for 18% share of all VC&PE investments in 2005.

The Lifesciences Sector is a key growth driver of India 's economy and the year 2005 will go down as the year of renaissance for the Lifesciences, bringing fresh vitality and vigour to the industry. Compliance with the TRIPS mandate at the beginning of 2005 has revolutionized the very identity of Indian pharmaceuticals and thrust it down the path of innovation. Today, India Inc. has become an integral part of the global Lifesciences market with a growing share in this space. Cost arbitrage and high quality capabilities are shifting global pharmaceutical attention to India, which could soon make it the pharmaceutical manufacturing hub of the world. Accelerated inroads into the biotech space and a healthcare industry on the verge of a boom, are attracting soaring global awareness presenting a plethora of opportunities.

AIMS AND OBJECTIVES

to analyse the growth trend and opportunities in the Lifesciences sector.
to gather experts from the industry to expand on the issues confronted by them and solutions that have been deployed.
to discuss the challenges in deployment of Private Equity for all the segments of the Lifesciences sector.
to discuss issues relating to legal, regulatory and tax pertaining to the lifescience sectors.
to understand the perspectives of investees and investors on Valuation and Due diligence.
to provide a unique opportunity to meet and network with decision makers and key players of the industry and the VC & PE community.

WHO SHOULD ATTEND

Promoters and Senior Executives of the Lifescience sector
PE & VC Practitioners
Fund Managers & HNI Investors
Legal Counsellors & Advisors
Consultants & Analysts

For more information, Please visit : http://www.bharatbook.com/general/Private-equity-Lifesciences.htm
Email : sony@bharatbook.com
You can also call us at +912227578668 or +912227579131